Biocon Limited (BSE: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, announced today that Anupam Jindal has been appointed as the company’s new Chief

Focuses on AI in Histopathology with emphasis on Breast Cancer Continuing with its transformative efforts in the field of Artificial Intelligence in Pathology, SRL Diagnostics,

In a case that provides hope for the treatment of patients suffering from covid19, medical specialists at Aster CMI Hospital successfully revived and gave

The team has shown results in treating Rabbits & is exploring funding opportunities for applications in Humans as Magnesium is the 4th abundant metal in

The eminent panellists present were Dr. Anil Khurana, Director General, Central Council for Research in Homoeopathy, Dr. R. K. Manchanda, Director AYUSH, Govt. of

·         India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, has been approved for use in India.    The Tata CRISPR test, powered by CSIR-IGIB

Niramai Health Analytix, India’s foremost and innovative AI-based breast cancer screening company has tied-up with Apollo Clinic, India’s leading multi-specialty clinics by Apollo Health

3 months old baby with severe Congenital Heart Defects (CHD) travelled through road in three states before getting treatment   A team of doctors at Fortis Escorts

Unlike the conventional pacemaker, this advanced technology helps in giving access to critical information anytime, anywhere. This novel pacemaker is a breakthrough concept

With an aim to provide end-to-end testing solutions, one of India’s leading and renowned diagnostic companies, Metropolis Healthcare Ltd has begun testing for Covid-19